Tremor in Parkinson's disease is not associated with the DRD3 Ser9Gly polymorphism

Parkinsonism and Related Disorders

Volumn 16, Issue 6, 2010, Pages 381-383

  Paus, S ^a   Gadow, F ^a   Kaut, O ^a   Knapp, M ^a   Klein, C ^b   Klockgether, T ^a   Wullner U ^a  

^a UNIVERSITY OF BONN   (Germany)

^b University Medical   (Germany)

Author keywords

DRD3 Ser9Gly; Essential tremor; Motor symptoms; Parkinson's disease

Indexed keywords

DOPAMINE 3 RECEPTOR;

ACTION TREMOR; ADULT; AGED; ARTICLE; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HYPOKINESIA; INATTENTION TREMOR; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PHENOTYPE; POSTURAL TREMOR; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYMPTOM; TREMOR;

AGED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, DOPAMINE D3; TREMOR;

EID: 77953615785     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2010.03.006     Document Type: Article

References (22)

1. Jankovic J., McDermott M., Carter J., Gauthier S., Goetz C., Golbe L., et al. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. Neurology 1990, 40:1529-1534. The Parkinson Study Group.
2. Lewis S.J., Foltynie T., Blackwell A.D., Robbins T.W., Owen A.M., Barker R.A. Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatr 2005, 76:343-348.
3. Jellinger K.A. Recent developments in the pathology of Parkinson's disease. J Neural Transm Suppl 2002, 62:347-376.
4. Antonini A., Moeller J.R., Nakamura T., Spetsieris P., Dhawan V., Eidelberg D. The metabolic anatomy of tremor in Parkinson's disease. Neurology 1998, 51:803-810.
5. Vingerhoets F.J., Schulzer M., Calne D.B., Snow B.J. Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion?. Ann Neurol 1997, 41:58-64.
6. Reijnders J.S., Ehrt U., Lousberg R., Aarsland D., Leentjens A.F. The association between motor subtypes and psychopathology in Parkinson's disease. Parkinsonism Relat Disord 2009 Jun, 15:379-382.
7. Jankovic J., Beach J., Schwartz K., Contant C. Tremor and longevity in relatives of patients with Parkinson's disease, essential tremor, and control subjects. Neurology 1995, 45:645-648.
8. Louis E.D., Levy G., Mejia-Santana H., Cote L., Andrews H., Harris J., et al. Risk of action tremor in relatives of tremor-dominant and postural instability gait disorder PD. Neurology 2003, 61:931-936.
9. Shahed J., Jankovic J. Exploring the relationship between essential tremor and Parkinson's disease. Parkinsonism Relat Disord 2007, 13:67-76.
10. Minen M.T., Louis E.D. Emergence of Parkinson's disease in essential tremor: a study of the clinical correlates in 53 patients. Mov Disord 2008, 23:1602-1605.
11. Tan E.K., Lee S.S., Fook-Chong S., Lum S.Y. Evidence of increased odds of essential tremor in Parkinson's disea se. Mov Disord 2008, 23:993-997.
12. Paus S., Gadow F., Knapp M., Klein C., Klockgether T., Wüllner U. Motor complications in patients form the German Competence Network on Parkinson's disease and the DRD3 Ser9Gly polymorphism. Mov Disord 2009, 24:1080-1084.
13. Jeanneteau F., Funalot B., Jankovic J., Deng H., Lagarde J.P., Lucotte G., et al. A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremor. PNAS 2006, 103:10753-10758.
14. Joyce J.N. Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs. Pharmacol Ther 2001, 90:231-259.
15. Keeling B.H., Vilariño-Güell C., Ross O.A., Wszolek Z.K., Uitti R.J., Farrer M.J. DRD3 Ser9Gly and HS1BP3 Ala265Gly are not associated with Parkinson disease. Neurosci Lett 2009, 461:74-75.
16. Kaiser R., Hofer A., Grapengiesser A., Gasser T., Kupsch A., Roots I., et al. L-dopa-induced adverse effects in PD and dopamine transporter gene polymorphism. Neurology 2003, 60:1750-1755.
17. Rajput A.H., Voll A., Rajput M.L., Robinson C.A., Rajput A. Course in Parkinson disease subtypes: a 39-year clinicopathologic study. Neurology 2009, 73:206-212.
18. Louis E.D., Levy G., Côte L.J., Mejia H., Fahn S., Marder K. Clinical correlates of action tremor in Parkinson disease. Arch Neurol 2001, 58:1630-1634.
19. Liu Y.Z., Tang B.S., Yan X.X., Liu J., Ouyang D.S., Nie L.N., et al. Association of the DRD2 and DRD3 polymorphisms with response to pramipexole in Parkinson's disease patients. Eur J Clin Pharmacol 2009, 65:679-683.
20. Josephs K.A., Matsumoto J.Y., Ahlskog J.E. Benign tremulous parkinsonism. Arch Neurol 2006, 63:354-357.
21. Clarimón J., Pagonabarraga J., Paisán-Ruíz C., Campolongo A., Pascual-Sedano B., Martí-Massó J.F., et al. Tremor dominant parkinsonism: clinical description and LRRK2 mutation screening. Mov Disord 2008, 23:518-523.
22. Lorenz D., Klebe S., Stevanin G., Thier S., Nebel A., Feingold J., et al. Dopamine receptor D3 gene and essential tremor in large series of German, Danish and French patients. Eur J Hum Genet 2009, 17:766-773.